共 46 条
- [45] A MULTICENTER PHASE II RANDOMIZED STUDY OF GEMCITABINE(G) WEEKLY FOLLOWED BY ERLOTINIB(E) AFTER PROGRESSION VERSUS E FOLLOWED BY G AFTER PROGRESSION IN ADVANCED NON SMALL CELL LUNG CANCER(NSCLC)IN VULNERABLE ELDERLY PATIENTS SELECTED WITH A COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) (GFPC*0505) JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1184 - S1184
- [46] A multicenter phase II ranomized study of gemcitabine (G) weekly followed by eriotinib (E) after progression versus E followed by G after progression in advance non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505) JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)